Summary by Moomoo AI
On July 3, 2024, Trifolium Biopharmaceutical Co., Ltd. ("Trifolium Biopharm-B") submitted the latest monthly securities change report to Hong Kong Exchanges and Clearing Limited, reporting the share changes up to June 30, 2024. The report shows that the company's statutory/registered share capital remains unchanged at a total of USD 200,000, with a par value of USD 0.0001 per share and a total number of 2,000,000,000 shares. As for the issued shares, the company only added 1,500 common shares in June, resulting in a total of 1,297,048,929 issued shares at the end of the month. In addition, both the pre-IPO stock option plan and the post-IPO stock option plan of the company's share option plan have changed, with the latter reducing by 2,523,213 shares due to the expiration of options. The company confirms that all sales or transfers of securities issuance or inventory shares have obtained formal authorization and approval from the board of directors, and comply with all applicable listing rules, laws and other regulatory requirements.